Lonza Group Ltd (LZAGF)
599.15
-4.00
(-0.66%)
USD |
OTCM |
Dec 16, 16:00
Lonza Group Market Cap: 43.21B for Dec. 16, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
CRISPR Therapeutics AG | 3.776B |
AC Immune SA | 288.91M |
Addex Therapeutics Ltd | 8.392M |
NLS Pharmaceutics Ltd | 7.096M |
Market Cap Related Metrics
PE Ratio | 67.58 |
PS Ratio | 5.792 |
Price to Book Value | 4.154 |
Price | 599.15 |
Earnings Yield | 1.48% |
Operating PE Ratio | 45.00 |
Normalized PE Ratio | 59.95 |